P1611: EFFICACY AND SAFETY OF AVATROMBOPAG FOR THE TREATMENT OF CHRONIC IMMUNE THROMBOCYTOPENIA IN A CHINESE ADULT POPULATION：A MULTICENTER, RANDOMIZED PHASE III TRIAL
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-08-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000973320.18602.7b |
| _version_ | 1797280918175481856 |
|---|---|
| author | Heng Mei Hu Zhou Ming Hou Jing Sun Lei Zhang Jianmin Luo Zhongxing Jiang Xu Ye Yajing Xu Jun Lu Hui Wang Aimin Hui Yongchun Zhou Yu Hu |
| author_facet | Heng Mei Hu Zhou Ming Hou Jing Sun Lei Zhang Jianmin Luo Zhongxing Jiang Xu Ye Yajing Xu Jun Lu Hui Wang Aimin Hui Yongchun Zhou Yu Hu |
| author_sort | Heng Mei |
| collection | DOAJ |
| first_indexed | 2024-03-07T16:48:05Z |
| format | Article |
| id | doaj.art-4efeabbfed804bc8bff61584aaae43a7 |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:48:05Z |
| publishDate | 2023-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-4efeabbfed804bc8bff61584aaae43a72024-03-03T06:24:32ZengWileyHemaSphere2572-92412023-08-017e186027b10.1097/01.HS9.0000973320.18602.7b202308003-01504P1611: EFFICACY AND SAFETY OF AVATROMBOPAG FOR THE TREATMENT OF CHRONIC IMMUNE THROMBOCYTOPENIA IN A CHINESE ADULT POPULATION：A MULTICENTER, RANDOMIZED PHASE III TRIALHeng Mei0Hu Zhou1Ming Hou2Jing Sun3Lei Zhang4Jianmin Luo5Zhongxing Jiang6Xu Ye7Yajing Xu8Jun Lu9Hui Wang10Aimin Hui11Yongchun Zhou12Yu Hu131 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Department of Hematology, wuhan, China2 Henan Cancer Hospital, Department of Hematology, Zhengzhou, China3 Qilu Hospital of Shandong University, Cancer Center, Jinan, China4 Nanfang Hospital, Department of Hematology, Guangzhou, China5 Institute of Hematology & Blood Diseases Hospital, Tianjin, China6 The Second Hospital of Hebei Medical University, Department of Hematology, Shijiazhuang, China7 The first Affiliated Hospital of Zhengzhou University, Zhengzhou, China8 The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China9 Xiangya Hospital, Central South University, Department of Hematology, Changsha, China10 Fosun Pharma, shanghai, China10 Fosun Pharma, shanghai, China10 Fosun Pharma, shanghai, China11 Wanbang Biopharmaceuticals, xuzhou, China1 Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Department of Hematology, wuhan, Chinahttp://journals.lww.com/10.1097/01.HS9.0000973320.18602.7b |
| spellingShingle | Heng Mei Hu Zhou Ming Hou Jing Sun Lei Zhang Jianmin Luo Zhongxing Jiang Xu Ye Yajing Xu Jun Lu Hui Wang Aimin Hui Yongchun Zhou Yu Hu P1611: EFFICACY AND SAFETY OF AVATROMBOPAG FOR THE TREATMENT OF CHRONIC IMMUNE THROMBOCYTOPENIA IN A CHINESE ADULT POPULATION：A MULTICENTER, RANDOMIZED PHASE III TRIAL HemaSphere |
| title | P1611: EFFICACY AND SAFETY OF AVATROMBOPAG FOR THE TREATMENT OF CHRONIC IMMUNE THROMBOCYTOPENIA IN A CHINESE ADULT POPULATION：A MULTICENTER, RANDOMIZED PHASE III TRIAL |
| title_full | P1611: EFFICACY AND SAFETY OF AVATROMBOPAG FOR THE TREATMENT OF CHRONIC IMMUNE THROMBOCYTOPENIA IN A CHINESE ADULT POPULATION：A MULTICENTER, RANDOMIZED PHASE III TRIAL |
| title_fullStr | P1611: EFFICACY AND SAFETY OF AVATROMBOPAG FOR THE TREATMENT OF CHRONIC IMMUNE THROMBOCYTOPENIA IN A CHINESE ADULT POPULATION：A MULTICENTER, RANDOMIZED PHASE III TRIAL |
| title_full_unstemmed | P1611: EFFICACY AND SAFETY OF AVATROMBOPAG FOR THE TREATMENT OF CHRONIC IMMUNE THROMBOCYTOPENIA IN A CHINESE ADULT POPULATION：A MULTICENTER, RANDOMIZED PHASE III TRIAL |
| title_short | P1611: EFFICACY AND SAFETY OF AVATROMBOPAG FOR THE TREATMENT OF CHRONIC IMMUNE THROMBOCYTOPENIA IN A CHINESE ADULT POPULATION：A MULTICENTER, RANDOMIZED PHASE III TRIAL |
| title_sort | p1611 efficacy and safety of avatrombopag for the treatment of chronic immune thrombocytopenia in a chinese adult population a multicenter randomized phase iii trial |
| url | http://journals.lww.com/10.1097/01.HS9.0000973320.18602.7b |
| work_keys_str_mv | AT hengmei p1611efficacyandsafetyofavatrombopagforthetreatmentofchronicimmunethrombocytopeniainachineseadultpopulationamulticenterrandomizedphaseiiitrial AT huzhou p1611efficacyandsafetyofavatrombopagforthetreatmentofchronicimmunethrombocytopeniainachineseadultpopulationamulticenterrandomizedphaseiiitrial AT minghou p1611efficacyandsafetyofavatrombopagforthetreatmentofchronicimmunethrombocytopeniainachineseadultpopulationamulticenterrandomizedphaseiiitrial AT jingsun p1611efficacyandsafetyofavatrombopagforthetreatmentofchronicimmunethrombocytopeniainachineseadultpopulationamulticenterrandomizedphaseiiitrial AT leizhang p1611efficacyandsafetyofavatrombopagforthetreatmentofchronicimmunethrombocytopeniainachineseadultpopulationamulticenterrandomizedphaseiiitrial AT jianminluo p1611efficacyandsafetyofavatrombopagforthetreatmentofchronicimmunethrombocytopeniainachineseadultpopulationamulticenterrandomizedphaseiiitrial AT zhongxingjiang p1611efficacyandsafetyofavatrombopagforthetreatmentofchronicimmunethrombocytopeniainachineseadultpopulationamulticenterrandomizedphaseiiitrial AT xuye p1611efficacyandsafetyofavatrombopagforthetreatmentofchronicimmunethrombocytopeniainachineseadultpopulationamulticenterrandomizedphaseiiitrial AT yajingxu p1611efficacyandsafetyofavatrombopagforthetreatmentofchronicimmunethrombocytopeniainachineseadultpopulationamulticenterrandomizedphaseiiitrial AT junlu p1611efficacyandsafetyofavatrombopagforthetreatmentofchronicimmunethrombocytopeniainachineseadultpopulationamulticenterrandomizedphaseiiitrial AT huiwang p1611efficacyandsafetyofavatrombopagforthetreatmentofchronicimmunethrombocytopeniainachineseadultpopulationamulticenterrandomizedphaseiiitrial AT aiminhui p1611efficacyandsafetyofavatrombopagforthetreatmentofchronicimmunethrombocytopeniainachineseadultpopulationamulticenterrandomizedphaseiiitrial AT yongchunzhou p1611efficacyandsafetyofavatrombopagforthetreatmentofchronicimmunethrombocytopeniainachineseadultpopulationamulticenterrandomizedphaseiiitrial AT yuhu p1611efficacyandsafetyofavatrombopagforthetreatmentofchronicimmunethrombocytopeniainachineseadultpopulationamulticenterrandomizedphaseiiitrial |